Zhejiang Cancer Hospital: all 281 studies

Page 3 of 3. Open to participants first (116), then studies with results posted, then the rest; newest registration first within each.

• Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric CancerStatus unknownNCT04135781Phase 3
• CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical CancerStatus unknownNCT04121975Phase 2
• Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed GlioblastomaCompletedNCT04119674Phase 1/2
• A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.SuspendedNCT04084158Phase 2
• TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) PatientsStatus unknownNCT04066543Phase 2
• A Study of Bortezomib Combined With CHEP in Peripheral T Cell LymphomaStatus unknownNCT04061772Phase 2
• Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell CarcinomaStatus unknownNCT04049344Phase 2
• A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal CancerStatus unknownNCT03940001Early Phase 1
• Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast CancerStatus unknownNCT03907098Phase 2
• Tegio Consolidation Therapy for NPC Patients With High Risk of MetastasisStatus unknownNCT03904225Phase 2
• Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBCStatus unknownNCT03876587Phase 2
• Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant ChemotherapyStatus unknownNCT03821454Not applicable
• The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast CancerStatus unknownNCT03756090Not applicable
• Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast CancerStatus unknownNCT03756064Not applicable
• Interleukin-11 Can Prevent and Treat of Radioactive Oral MucitisStatus unknownNCT03720340Phase 3
• A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCCStatus unknownNCT03678649Phase 2
• Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined ChemotherapyStatus unknownNCT03647527
• Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast CancerStatus unknownNCT03647514Not applicable
• The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT03647280Not applicable
• Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant TherapyStatus unknownNCT03638648Phase 2
• Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast CancerStatus unknownNCT03618810
• Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal CancerStatus unknownNCT03615170
• TOMO Versus IMRT in Nasopharyngeal Carcinoma PatientsStatus unknownNCT03588403
• Individualized Pharmaceutical-care for Inpatients With Cancer PainStatus unknownNCT03455023Not applicable
• Individualized Pharmaceutical-care in Outpatients With Cancer PainStatus unknownNCT03439904Not applicable
• Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma PatientsStatus unknownNCT03411954
• Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous CarcinomaCompletedNCT03381651Not applicable
• Remifemin Preventing the Climacteric Symptoms in Breast CancerCompletedNCT03339882Phase 2
• DEB-TACE Treatment in 367 Liver Cancer PatientsCompletedNCT03317483
• A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast CancerStatus unknownNCT03280134Not applicable
• Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric CancerStatus unknownNCT03276156Phase 1
• Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)Status unknownNCT03213587Phase 2
• Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast CancerStatus unknownNCT03204734Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical CancerStatus unknownNCT03175848Not applicable
• Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast CancerStatus unknownNCT03147963Phase 2
• Monosialoganglioside Ganglioside in Cerebral Radiation NecrosisStatus unknownNCT03067753Phase 2
• Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT03058432Phase 2
• Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT03025958Phase 2
• Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal CarcinomaStatus unknownNCT03015727Phase 3
• A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma PatientsStatus unknownNCT02948699Phase 4
• Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal CarcinomaStatus unknownNCT02945878
• Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive DysfunctionCompletedNCT02923128Phase 4
• Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC)Status unknownNCT02906384Phase 2
• A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.Status unknownNCT02878889Phase 2
• S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal CancerCompletedNCT02813967Phase 3
• Acquired Resistant Mechanism of the First-generation EGFR TKIsStatus unknownNCT02804217
• Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast CancerStatus unknownNCT02769104Phase 3
• Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical StudyStatus unknownNCT02702323Phase 2/3
• Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT02663440Phase 2
• Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast CancerStatus unknownNCT02649101Phase 2
• A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)Status unknownNCT02597868Not applicable
• A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT02570893Phase 3
• HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal MetastasisStatus unknownNCT02549911Phase 2
• Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLCStatus unknownNCT02481661Phase 3
• Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain MetastasesStatus unknownNCT02385136Phase 1/2
• Comparable Study of Different Radiation Dose in Esophageal CarcinomaStatus unknownNCT01937208Phase 3
• Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by ResectionStatus unknownNCT01926483Phase 2
• Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01915134Phase 3
• Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal CancerStatus unknownNCT01899118Phase 2
• D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric CancerStatus unknownNCT01836991Phase 2
• Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal CancerStatus unknownNCT01832948Phase 2
• Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric CancerStatus unknownNCT01756183Phase 2
• Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLCCompletedNCT01733589Phase 1/2
• A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung CancerStatus unknownNCT01731548Phase 2/3
• Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung CancerStatus unknownNCT01688713Phase 2
• Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell CarcinomaStatus unknownNCT01688700Phase 2
• Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung CancerStatus unknownNCT01635400Phase 2
• Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01612286Phase 2
• Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric CancerStatus unknownNCT01558947Phase 2
• Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal CarcinomaStatus unknownNCT01536223Phase 3
• Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung CancerCompletedNCT01514877Phase 2
• Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal CancerStatus unknownNCT01463501Phase 2
• Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal CancerStatus unknownNCT01291823Phase 2
• Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer PatientsCompletedNCT01258192Phase 2
• S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal CancerCompletedNCT01175460Phase 1
• S-1 and Radiotherapy in Elderly Patients With Esophageal CancerCompletedNCT01175447Phase 1
• Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)Status unknownNCT01158170Phase 3
• Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)Status unknownNCT01158144Phase 2
• Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)Status unknownNCT01091376Phase 2
• A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)Status unknownNCT00886678Phase 2
• Zoladex Plus Tamoxifen in Breast CancerCompletedNCT00827307Not applicable

← Zhejiang Cancer Hospital overview and focus areas